Novartis gene therapy approval signals new cancer treatment era

(Reuters) - Novartis AG on Wednesday won highly anticipated U.S. approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, a $475,000 treatment that marks the start of a potential new treatment paradigm for some cancers.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news